PURPOSE: Quantitative MRI T2 mapping is a non-invasive imaging technique sensitive to biochemical changes, but no studies have evaluated T2 mapping in pathologic rotator cuff tendons. It was sought to evaluate the efficacy of T2 mapping in detecting differences in the supraspinatus tendon (SST) among patients with tendinosis, partial tears and minimally retracted full-thickness tears, relative to asymptomatic volunteers. METHODS: The pathologic cohort consisted of two arthroscopically verified groups: tendinosis and a tear group of partial tears or minimally retracted full-thickness tears, and was compared to an asymptomatic cohort with no prior history of shoulder pathology. The SST was manually segmented from the footprint to the medial humeral head in the coronal and sagittal planes and divided into six clinically relevant subregions. Mean T2 values and inter- and intra-rater reliability were assessed. RESULTS: In the anterolateral subregion, the tear group exhibited significantly higher mean T2 values (43.9 ± 12.7 ms) than the tendinosis (34.9 ± 3.9 ms; p = 0.006) and asymptomatic (33.6 ± 5.3 ms; p = 0.015) groups. In the posterolateral subregion, the tear group had higher mean T2 values (45.2 ± 13.7) than the asymptomatic group (34.7 ± 6.7; p = 0.012). Inter- and intra-rater reliability was mostly excellent (ICC > 0.75). CONCLUSION: T2 mapping is an accurate non-invasive method to identify quantitatively early rotator cuff pathology. The lateral region in the coronal plane in particular may differentiate partial and small minimally retracted full-thickness tears from tendinosis and asymptomatic tendons. Understanding and being able to measure quantitatively the process of tendon degeneration and subsequent tearing may help clinicians to better predict at-risk groups and to stratify treatment options. LEVEL OF EVIDENCE: III.
PURPOSE: Quantitative MRI T2 mapping is a non-invasive imaging technique sensitive to biochemical changes, but no studies have evaluated T2 mapping in pathologic rotator cuff tendons. It was sought to evaluate the efficacy of T2 mapping in detecting differences in the supraspinatus tendon (SST) among patients with tendinosis, partial tears and minimally retracted full-thickness tears, relative to asymptomatic volunteers. METHODS: The pathologic cohort consisted of two arthroscopically verified groups: tendinosis and a tear group of partial tears or minimally retracted full-thickness tears, and was compared to an asymptomatic cohort with no prior history of shoulder pathology. The SST was manually segmented from the footprint to the medial humeral head in the coronal and sagittal planes and divided into six clinically relevant subregions. Mean T2 values and inter- and intra-rater reliability were assessed. RESULTS: In the anterolateral subregion, the tear group exhibited significantly higher mean T2 values (43.9 ± 12.7 ms) than the tendinosis (34.9 ± 3.9 ms; p = 0.006) and asymptomatic (33.6 ± 5.3 ms; p = 0.015) groups. In the posterolateral subregion, the tear group had higher mean T2 values (45.2 ± 13.7) than the asymptomatic group (34.7 ± 6.7; p = 0.012). Inter- and intra-rater reliability was mostly excellent (ICC > 0.75). CONCLUSION: T2 mapping is an accurate non-invasive method to identify quantitatively early rotator cuff pathology. The lateral region in the coronal plane in particular may differentiate partial and small minimally retracted full-thickness tears from tendinosis and asymptomatic tendons. Understanding and being able to measure quantitatively the process of tendon degeneration and subsequent tearing may help clinicians to better predict at-risk groups and to stratify treatment options. LEVEL OF EVIDENCE: III.
Entities:
Keywords:
MRI; Partial and full tear; Rotator cuff; Supraspinatus; T2 mapping; Tendinosis
Authors: Michael Khazzam; John E Kuhn; Ed Mulligan; Joseph A Abboud; Keith M Baumgarten; Robert H Brophy; Grant L Jones; Bruce Miller; Matthew Smith; Rick W Wright Journal: Am J Sports Med Date: 2012-06-15 Impact factor: 6.202
Authors: H Mike Kim; Nirvikar Dahiya; Sharlene A Teefey; William D Middleton; Georgia Stobbs; Karen Steger-May; Ken Yamaguchi; Jay D Keener Journal: J Bone Joint Surg Am Date: 2010-05 Impact factor: 5.284
Authors: Edwin E Spencer; Warren R Dunn; Rick W Wright; Brian R Wolf; Kurt P Spindler; Eric McCarty; C Benjamin Ma; Grant Jones; Marc Safran; G Brian Holloway; John E Kuhn Journal: Am J Sports Med Date: 2007-10-11 Impact factor: 6.202
Authors: Adam W Anz; Erin P Lucas; Eric K Fitzcharles; Rachel K Surowiec; Peter J Millett; Charles P Ho Journal: Eur J Radiol Date: 2014-02-14 Impact factor: 3.528
Authors: Vladimir Juras; Sebastian Apprich; Christina Pressl; Stefan Zbyn; Pavol Szomolanyi; Stephan Domayer; Jochen G Hofstaetter; Siegfried Trattnig Journal: Eur J Radiol Date: 2011-12-15 Impact factor: 3.528
Authors: Augustus D Mazzocca; Lina M Rincon; Robert W O'Connor; Elifho Obopilwe; Matthew Andersen; Lauren Geaney; Robert A Arciero Journal: Am J Sports Med Date: 2007-09-20 Impact factor: 6.202
Authors: Konstantin Krepkin; Mary Bruno; José G Raya; Ronald S Adler; Soterios Gyftopoulos Journal: Skeletal Radiol Date: 2016-11-28 Impact factor: 2.199
Authors: Carly A Lockard; Katharine J Wilson; Charles P Ho; Richard C Shin; J Christoph Katthagen; Peter J Millett Journal: Skeletal Radiol Date: 2017-12-01 Impact factor: 2.199
Authors: Ashlee E Watts; Neal L Millar; Josh Platt; Susan M Kitson; Moeed Akbar; Raquel Rech; Jay Griffin; Roy Pool; Tom Hughes; Iain B McInnes; Derek S Gilchrist Journal: Mol Ther Date: 2017-07-28 Impact factor: 11.454
Authors: Carly A Lockard; Philip-C Nolte; Karissa M B Gawronski; Bryant P Elrick; Brandon T Goldenberg; Marilee P Horan; Grant J Dornan; Charles P Ho; Peter J Millett Journal: Eur J Radiol Open Date: 2021-02-13
Authors: Guy Trudel; Samuel Duchesne-Bélanger; Justin Thomas; Gerd Melkus; Greg O Cron; Peder E Z Larson; Mark Schweitzer; Adnan Sheikh; Hakim Louati; Odette Laneuville Journal: Quant Imaging Med Surg Date: 2021-08